TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

21.130 Sorrell MF et al. National Institutes of Health Consensus Development conference statement: management
of hepatitis B. Ann Intern Med 2009;150:104-10.
21.131 Cooke GS et al. Treatment for hepatitis B. Br Med J 2010;340:87-91.
21.132 Alazawi W et al. Advances in the diagnosis and treatment of hepatitis B. Curr Opin Infect Dis 2008;
21:508-15.
21.133 Singh NA et al. Management of hepatitis B virus. J Antimicrob Chemother 2008;62:224-8.
21.134 Liaw YF et al. Hepatitis B virus infection. Lancet 2009;373:582-92.
21.135 Coffin CS et al. Management of patients co-infected with HBV and HCV. Expert Rev Anti Infect
Ther 2009;7:549-58.
21.136 Keeffe EB et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the
United States: an update. Clin Gastroenterol Hepatol 2006;4:936-62.
21.137 Lok AS et al. Chronic hepatitis B. Hepatology 2007;45:507-39.
21.138 Lai CL et al. The natural history and treatment of chronic hepatitis B: a critical evaluation of standard
treatment criteria and endpoints. Ann Intern Med 2007;147:58-61.
21.139 Di Marco V et al. Chronic hepatitis B: who to treat and which choice of treatment? Expert Rev Anti
Infect Ther 2009;7:281-9.
21.140 Mauss S et al. Treatment of chronic hepatitis B and the implications of viral resistance to therapy. Expert
Rev Anti Infect Ther 2008;6:191-9.
21.141 Wong VW et al. Antiviral therapy for chronic hepatitis B: are we doing any good to patients? J
Antimicrob Chemother 2009;64:223-6.
21.142 Papatheotoridis GV et al. Therapeutic strategies in the management of patients with chronic hepatitis
B virus infection. Lancet Infect Dis 2008;8:167-78.
21.143 Centers for Disease Control and Prevention (CDC). Recommendations for identification and public
health management of persons with chronic hepatitis B virus infection. Morb Mortal Wkly Rep 2008;
57(RR-8):1-20.
21.144 Dienstag JL. Hepatitis B virus infection. N Engl J Med 2008;359:1486-500.
21.145 Pungpapong S et al. Natural history of hepatitis B virus infections: an update for clinicians. Mayo Clin
Proc 2007;82:967-75.
21.146 Iorio R et al. Long-term outcome in children with chronic hepatitis B: a 24-year observation period.
Clin Infect Dis 2007;45:943-9.
21.147 Hardikar W et al. Treatment options for chronic hepatitis B and C in children. Expert Rev Anti Infect
Ther 2006;4:583-91.
21.148 Ghany MG et al. Assessment and management of chronic hepatitis B. Infect Dis Clin North Am
2006;20:63-79.
21.149 Robins GW et al. Peginterferon-α-2a (40KD). A review of its use in the management of patients with
chronic hepatitis B. Drugs 2005;65:809-25.
21.150 Van Bömmel F et al. Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected
patients after failure of nucleoside/nucleotide analogues. Hepatology 2010;51:73-80.
21.151 Marcellin P et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. N
Engl J Med 2008;359:2442-55.
21.152 Hadziyannis SJ et al. Long term therapy with adefovir dipivoxil for HBeAg negative chronic hepatitis
B. N Engl J Med 2005;352:2673-81.
21.153 Hadziyannis SJ et al. Adefovir dipivoxil in the treatment of chronic hepatitis B virus infection. Expert
Rev Anti Infect Ther 2004;2:475-83.
21.154 Gonzalez SA et al. Entecavir for the long-term treatment of chronic hepatitis B. Expert Rev Anti Infect
Ther 2009;7:1053-62.
21.155 Goulis I et al. Entecavir monotherapy for lamivudine refractory chronic hepatitis B. Expert Rev Anti
Infect Ther 2008;6:855-9.
21.156 Lai CL et al. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B. N
Engl J Med 2006;354:1011-20.
21.157 Chang TT et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N
Engl J Med 2006;354:1001-10.
21.158 Shaw T et al. Entecavir for the treatment of chronic hepatitis B. Expert Rev Anti Infect Ther 2004;2:
853-71.
21.159 Leung N. Lamivudine for chronic hepatitis B. Expert Rev Anti Infect Ther 2004;2:173-80.
21.160 Nash KL et al. The case for combination antiviral therapy for chronic hepatitis B virus infection. Lancet
Infect Dis 2008;8:444-8.
21.161 Lau GK et al. Peginterferon alfa-2a, lamivudine and the combination for HBeAG-positive chronic hepatitis
B. N Engl J Med 2005;352:2682-95.
21.162 Janssen HL et al. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg
positive chronic hepatitis B: a randomised trial. Lancet 2005;365:123-9.
21.163 Yuen MF et al. Prevention and management of drug resistance for antihepatitis B treatment. Lancet
Infect Dis 2009;9:256-64.
21.164 Pol S et al. Management of chronic hepatitis C virus infection in HIV-infected patients. Clin Infect Dis
2008;47:94-101.
21.165 Koziel MJ et al. Viral hepatitis in HIV infection. N Engl J Med 2007;356:1445-54.
21.166 Cacoub P. Treatment of hepatitis C in HIV/hepatitis C co-infected patients: what is the evidence? Int
J STD AIDS 2005;16:1-4.
21.167 Bräu N. Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected
patients in the era of pegylated interferon and ribavirin. Semin Liver Dis 2005:25:33-51.
21.168 Dore GJ et al. Management and treatment of injection drug users with hepatitis C virus (HCV) infection
and HCV/human immunodeficiency virus coinfection. Semin Liver Dis 2005;25:18-32.
21.169 Sherman KE. Treatment of hepatitis C virus and human immunodeficiency virus co-infection. Clin
Gastroenterol Hepatol 2005;3(suppl. 2):S118-21.
21.170 Soriano V et al. New paradigms in the management of HIV and hepatitis C virus co-infection. Curr
Opin Infect Dis 2005;18:550-60.
21.171 Rockstroh JK. Management of hepatitis C/HIV co-infection. Curr Opin Infect Dis 2006;19:8-13.
21.172 Pawlotsky JM. Current and future concepts in hepatitis C therapy. Semin Liver Dis 2005;25:72-83.
21.173 Scott JD et al. Molecular diagnostics of hepatitis C virus infection. A systematic review. J Am Med
Assoc 2007;297:724-32.
21.174 Gasink LB et al. Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.
J Am Med Assoc 2006;296:1843-50.
21.175 Biggins SW et al. Management of recurrent hepatitis C in liver transplant recipients. Infect Dis Clin